{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:01:30Z","timestamp":1792011690863,"version":"4.4.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:sec id=\"ab-eoi250063-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Geographic atrophy (GA) progression represents the combination of contiguous expansion and new lesion addition. Multifocal GA is associated with faster area-based progression and has been linked to faster decline in visual acuity, but the natural history and risk factors for new lesion addition are unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250063-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine, in eyes with preexisting GA, the natural history of new GA lesion incidence and identify risk factors for faster incidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250063-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This was a post hoc analysis of the Age-Related Eye Disease Study 2 (AREDS2), which was a multicenter study based in retinal specialty clinics in the US. Included in the analysis were eyes with incident GA considered in 2 cohorts: (1) any-focality GA (eyes with unifocal or multifocal GA at incidence) and (2) unifocal GA (eyes with unifocal GA at incidence). Study data were analyzed from January to May 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250063-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Demographic and dietary characteristics, genotype, GA characteristics, and macular features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250063-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was new GA lesion incidence rate, after GA incidence. Annual fundus photographs were graded for GA presence and characteristics and macular features. After GA incidence, new GA lesion incidence events were recorded. Univariable and multivariable analyses were performed by generalized estimating equations regression, with least absolute shrinkage and selection operator regression for variable screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250063-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 689 eyes with incident GA of 570 participants (mean [SD] age, 74.5 [6.9] years; 332 female [58.2%]) were included in this study. Eyes constituted 2 main cohorts: (1) any-focality GA (ie, 689 eyes with unifocal or multifocal GA at incidence) and (2) unifocal GA (ie, 386 eyes with unifocal GA at incidence). Over a mean (SD) follow-up of 2.1 (0.9) years, the mean (SD) GA lesion incidence rate was 0.25 (0.50) lesions per year (range, 0-3 lesions per year) and 0.40 (0.70) lesions per year  (range, 0-5 lesions per year) in the unifocal and any-focality cohorts, respectively. For the unifocal cohort, the multivariable model comprised 4 risk factors: reticular pseudodrusen (RPD), noncentral GA, lower nut intake, and higher calorie intake. For the any-focality cohort, the model comprised 7 risk factors: GA lesion number, noncentral GA, greater GA proximity to central macula, RPD, age, lower fish intake, and higher calorie intake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250063-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this post hoc analysis of the AREDS2 trial data, the natural history data and multivariable models may be helpful in clinical practice and trials. The models included a combination of GA characteristics and RPD status; the risk factors for first GA occurrence, subsequent lesion incidence rate, and area-based progression overlapped only partially. Their mechanisms may, therefore, be partially distinct, which has implications for therapeutic approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2025.3979","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:31:14Z","timestamp":1762446674000},"page":"1014","source":"Crossref","is-referenced-by-count":6,"title":["Geographic Atrophy Multifocality in the Age-Related Eye Disease Study 2"],"prefix":"10.1001","volume":"143","author":[{"given":"Leon","family":"von der Emde","sequence":"first","affiliation":[{"name":"Multidisciplinary Retinal Research Unit, Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"},{"name":"Department of Ophthalmology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintong","family":"Hou","sequence":"additional","affiliation":[{"name":"Multidisciplinary Retinal Research Unit, Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souvick","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Multidisciplinary Retinal Research Unit, Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Vance","sequence":"additional","affiliation":[{"name":"Multidisciplinary Retinal Research Unit, Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Agr\u00f3n","sequence":"additional","affiliation":[{"name":"Multidisciplinary Retinal Research Unit, Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitha","family":"Domalpally","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiarn\u00e1n D. L.","family":"Keenan","sequence":"additional","affiliation":[{"name":"Multidisciplinary Retinal Research Unit, Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AREDS2 Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"eoi250063r1","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16.","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi250063r2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration.","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi250063r3","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1167\/iovs.17-22339","article-title":"Report from the NEI\/FDA end points workshop on age-related macular degeneration and inherited retinal diseases.","volume":"58","author":"Csaky","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10411","key":"eoi250063r4","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): 2 multicenter, randomized, double-masked, sham-controlled, phase 3 trials.","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"issue":"10411","key":"eoi250063r5","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomized, double-masked, phase 3 trial.","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"eoi250063r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100306","article-title":"Geographic atrophy in age-related macular degeneration: a tale of 2 stages.","volume":"3","author":"Keenan","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"3","key":"eoi250063r7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/jamaophthalmol.2021.6067","article-title":"Association of pegcetacoplan with progression of incomplete retinal pigment epithelium and outer retinal atrophy in age-related macular degeneration: a post hoc analysis of the FILLY randomized clinical trial.","volume":"140","author":"Nittala","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eoi250063r8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00417-024-06676-7","article-title":"Progression to complete retinal pigment epithelium and outer retinal atrophy (cRORA): post hoc analysis of the GATHER1 trial.","volume":"263","author":"Corradetti","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"eoi250063r9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3.","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi250063r10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.oret.2020.03.020","article-title":"Progression of unifocal versus multifocal geographic atrophy in age-related macular degeneration: a systematic review and meta-analysis.","volume":"4","author":"Shen","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"eoi250063r11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ophtha.2025.01.028","article-title":"Determinants of 4-year visual acuity loss in geographic atrophy: an analysis of Age-Related Eye Disease Study and Age-Related Eye Disease Study 2.","volume":"132","author":"Shen","year":"2025","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi250063r12","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).","volume":"119","author":"Chew","year":"2012","journal-title":"Ophthalmology"},{"issue":"7","key":"eoi250063r13","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1167\/iovs.13-11804","article-title":"Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 report number 2).","volume":"54","author":"Danis","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi250063r14","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/jamia\/ocaa302","article-title":"Multimodal, multitask, multiattention (M3) deep learning detection of reticular pseudodrusen: toward automated and accessible classification of age-related macular degeneration.","volume":"28","author":"Chen","year":"2021","journal-title":"J Am Med Inform Assoc"},{"issue":"2","key":"eoi250063r15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants.","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"issue":"11","key":"eoi250063r16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.oret.2021.07.006","article-title":"Cluster analysis and genotype-phenotype assessment of geographic atrophy in age-related macular degeneration: Age-Related Eye Disease Study 2 report 25.","volume":"5","author":"Keenan","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"eoi250063r17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.oret.2020.04.014","article-title":"Genotype- and phenotype-based subgroups in geographic atrophy secondary to age-related macular degeneration: the EYE-RISK Consortium.","volume":"4","author":"Biarn\u00e9s","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"eoi250063r18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126636","article-title":"Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration.","volume":"10","author":"Grassmann","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"eoi250063r19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ophtha.2023.09.013","article-title":"Critical dependence on area in relationship between ARMS2\/HTRA1 genotype and faster geographic atrophy enlargement: Age-Related Eye Disease Study 2 report number 33.","volume":"131","author":"Agr\u00f3n","year":"2024","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi250063r20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ophtha.2022.11.026","article-title":"Reticular pseudodrusen status, ARMS2\/HTRA1 genotype, and geographic atrophy enlargement: Age-Related Eye Disease Study 2 report 32.","volume":"130","author":"Agron","year":"2023","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi250063r21","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.ophtha.2020.04.030","article-title":"Adherence to the Mediterranean diet and progression to late age-related macular degeneration in the Age-Related Eye Disease Studies 1 and 2.","volume":"127","author":"Keenan","year":"2020","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi250063r22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.oret.2022.03.022","article-title":"Adherence to a Mediterranean diet and geographic atrophy enlargement rate: Age-Related Eye Disease Study 2 report 29.","volume":"6","author":"Agr\u00f3n","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"eoi250063r23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/nu17050771","article-title":"Relationships between diet and geographic atrophy progression in the Age-Related Eye Diseases Studies 1 and 2.","volume":"17","author":"Agr\u00f3n","year":"2025","journal-title":"Nutrients"},{"issue":"4","key":"eoi250063r24","first-page":"283","article-title":"Associations of plasma carotenoid concentrations and dietary intake of specific carotenoids in samples of 2 prospective cohort studies using a new carotenoid database.","volume":"7","author":"Michaud","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"eoi250063r25","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/oxfordjournals.aje.a116211","article-title":"Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals.","volume":"135","author":"Rimm","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"1","key":"eoi250063r26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3945\/ajcn.113.068106","article-title":"The Mediterranean-style dietary pattern and mortality among men and women with cardiovascular disease.","volume":"99","author":"Lopez-Garcia","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"eoi250063r27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ophtha.2022.05.021","article-title":"Reticular pseudodrusen: the third macular risk feature for progression to late age-related macular degeneration: Age-Related Eye Disease Study 2 report 30.","volume":"129","author":"Agr\u00f3n","year":"2022","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi250063r28","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.ophtha.2024.04.011","article-title":"An updated simplified severity scale for age-related macular degeneration incorporating reticular pseudodrusen: Age-Related Eye Disease Study report number 42.","volume":"131","author":"Agr\u00f3n","year":"2024","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi250063r29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.oret.2023.12.006","article-title":"OCT prognostic biomarkers for progression to late age-related macular degeneration: a systematic review and meta-analysis.","volume":"8","author":"Trinh","year":"2024","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"eoi250063r30","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s00394-018-1771-5","article-title":"Food groups and risk of age-related macular degeneration: a systematic review with meta-analysis.","volume":"58","author":"Dinu","year":"2019","journal-title":"Eur J Nutr"},{"issue":"11","key":"eoi250063r31","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","article-title":"The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report No. 17.","volume":"123","author":"Davis","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"eoi250063r32","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ophtha.2007.08.030","article-title":"Retinal precursors and the development of geographic atrophy in age-related macular degeneration.","volume":"115","author":"Klein","year":"2008","journal-title":"Ophthalmology"},{"issue":"7","key":"eoi250063r33","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ophtha.2020.11.024","article-title":"Genetic risk, lifestyle, and age-related macular degeneration in Europe: the EYE-RISK Consortium.","volume":"128","author":"Colijn","year":"2021","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi250063r34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1534\/genetics.116.196998","article-title":"Bivariate analysis of age-related macular degeneration progression using genetic risk scores.","volume":"206","author":"Ding","year":"2017","journal-title":"Genetics"},{"issue":"7","key":"eoi250063r35","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ophtha.2022.02.026","article-title":"The phenotypic course of age-related macular degeneration for ARMS2\/HTRA1: the EYE-RISK Consortium.","volume":"129","author":"Thee","year":"2022","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi250063r36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/imr.13145","article-title":"Age-related macular degeneration: a disease of extracellular complement amplification.","volume":"313","author":"de Jong","year":"2023","journal-title":"Immunol Rev"},{"key":"eoi250063r37","doi-asserted-by":"publisher","first-page":"26568","DOI":"10.1038\/srep26568","article-title":"A novel complotype combination associates with age-related macular degeneration and high complement activation levels in vivo.","volume":"6","author":"Paun","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"eoi250063r38","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.ophtha.2020.12.030","article-title":"Re: Jaffe et al: C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial (Ophthalmology. 2021;128:576-586).","volume":"128","author":"Keenan","year":"2021","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi250063r39","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.ophtha.2016.06.025","article-title":"Evaluation of geographic atrophy from color photographs and fundus autofluorescence images: Age-Related Eye Disease Study 2 report number 11.","volume":"123","author":"Domalpally","year":"2016","journal-title":"Ophthalmology"},{"issue":"395","key":"eoi250063r40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration.","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci Transl Med"},{"issue":"9","key":"eoi250063r41","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1097\/IAE.0b013e3182509778","article-title":"Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area.","volume":"32","author":"Khanifar","year":"2012","journal-title":"Retina"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2840920\/jamaophthalmology_von_der_emde_2025_oi_250063_1765550200.37554.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:01:01Z","timestamp":1766073661000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2840920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.3979","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}